Frank Hermann

Frank Hermann, MD, currently serves as Chief Medical Officer at Thermosome since December 2023. Prior roles include Vice President of Clinical Development at CatalYm GmbH, Senior Director of Clinical Development in Oncology at BioNTech SE, and Chief Development Officer at 4SC AG. Hermann has also held positions at Bristol-Myers Squibb as Associate Medical Director in Immuno-Oncology and Medical Advisor for Oncology. Earlier in the career, Hermann was a Resident in Pediatrics, Pediatric Oncology, and Pediatric Radiology at Justus-Liebig University Giessen. Educational qualifications include a Doctor of Medicine degree from Johannes Gutenberg University Mainz and earlier studies at Gustav-Stresemann Academic High School.